Physician profile
Owen Files
NPI 1952974842
$3,802.66
in general payments reported to CMS, 2019-2025
21 companies · $897 in 2025
The $897 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $370 · 2022: $663 · 2023: $1,114 · 2024: $758 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,264 · Consulting Fee: $450 · Entertainment: $55.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,263.93 |
| Consulting Fee | $450.00 |
| Entertainment | $55.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $720.22 | 2021-2025 | Istent Trabecular Micro-Bypass Stent System, Photrexa Viscous and Photrexa, Idosetr |
| Alcon Vision LLC | $638.34 | 2021-2025 | Tryptyr, Hydrus Microstent, Precision7 |
| Rxsight INC | $384.47 | 2022-2023 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal) |
| Johnson & Johnson Surgical Vision, INC. | $297.90 | 2023-2024 | Tecnis Iol, Catalys System |
| Biotissue Holdings INC. | $249.19 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $189.92 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $160.13 | 2022-2025 | Tearcare System, Omni Surgical System |
| Dompe US, INC. | $137.65 | 2024-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $133.20 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2022 | |
| Allergan, INC. | $122.97 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $121.24 | 2023-2025 | Cequa |
| Mallinckrodt Hospital Products INC. | $95.05 | 2024 | Acthar |
| Coopervision INC. | $93.95 | 2023-2025 | Clariti Contact Lens, Clearsight Contact Lens |
| Genentech USA, INC. | $90.01 | 2023 | Vabysmo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $82.49 | 2022 | |
| Optos, INC. | $55.83 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.89 | 2021 | |
| Ocular Therapeutix, INC. | $26.35 | 2024 | Dextenza |
| Oyster Point Pharma, INC. | $24.22 | 2022 | |
| Harrow Eye, LLC | $19.64 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Owen Files listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.